116 related articles for article (PubMed ID: 34216846)
1. Structural volume and cortical thickness differences between males and females in cognitively normal, cognitively impaired and Alzheimer's dementia population.
Sangha O; Ma D; Popuri K; Stocks J; Wang L; Beg MF; ;
Neurobiol Aging; 2021 Oct; 106():1-11. PubMed ID: 34216846
[TBL] [Abstract][Full Text] [Related]
2. Cortical thickness in relation to clinical symptom onset in preclinical AD.
Pettigrew C; Soldan A; Zhu Y; Wang MC; Moghekar A; Brown T; Miller M; Albert M;
Neuroimage Clin; 2016; 12():116-22. PubMed ID: 27408796
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
4. Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort.
Wang ML; Wei XE; Yu MM; Li PY; Li WB;
Neurosci Lett; 2017 Aug; 655():115-120. PubMed ID: 28689050
[TBL] [Abstract][Full Text] [Related]
5. Cognitive reserve and cortical thickness in preclinical Alzheimer's disease.
Pettigrew C; Soldan A; Zhu Y; Wang MC; Brown T; Miller M; Albert M;
Brain Imaging Behav; 2017 Apr; 11(2):357-367. PubMed ID: 27544202
[TBL] [Abstract][Full Text] [Related]
6. Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.
Tuwaig M; Savard M; Jutras B; Poirier J; Collins DL; Rosa-Neto P; Fontaine D; Breitner JCS;
J Alzheimers Dis; 2017; 60(4):1589-1600. PubMed ID: 28984583
[TBL] [Abstract][Full Text] [Related]
7. Graph theoretic analysis of structural connectivity across the spectrum of Alzheimer's disease: The importance of graph creation methods.
Phillips DJ; McGlaughlin A; Ruth D; Jager LR; Soldan A;
Neuroimage Clin; 2015; 7():377-90. PubMed ID: 25984446
[TBL] [Abstract][Full Text] [Related]
8. It is unclear if adjusting cortical thickness for changes in gray/white matter intensity ratio improves discrimination between normal aging, MCI, and AD.
Bauer CM; Cabral HJ; Killiany RJ;
Brain Imaging Behav; 2014 Mar; 8(1):133-40. PubMed ID: 24535034
[TBL] [Abstract][Full Text] [Related]
9. Selective disruption of the cerebral neocortex in Alzheimer's disease.
Desikan RS; Sabuncu MR; Schmansky NJ; Reuter M; Cabral HJ; Hess CP; Weiner MW; Biffi A; Anderson CD; Rosand J; Salat DH; Kemper TL; Dale AM; Sperling RA; Fischl B;
PLoS One; 2010 Sep; 5(9):e12853. PubMed ID: 20886094
[TBL] [Abstract][Full Text] [Related]
10. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
11. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
[TBL] [Abstract][Full Text] [Related]
12. Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features.
Li Y; Wang Y; Wu G; Shi F; Zhou L; Lin W; Shen D;
Neurobiol Aging; 2012 Feb; 33(2):427.e15-30. PubMed ID: 21272960
[TBL] [Abstract][Full Text] [Related]
13. Structural Brain Differences Between Cognitively Impaired Patients With and Without Apathy.
Chan NK; Gerretsen P; Chakravarty MM; Blumberger DM; Caravaggio F; Brown E; Graff-Guerrero A;
Am J Geriatr Psychiatry; 2021 Apr; 29(4):319-332. PubMed ID: 33423870
[TBL] [Abstract][Full Text] [Related]
14. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
[TBL] [Abstract][Full Text] [Related]
16. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O
Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656
[TBL] [Abstract][Full Text] [Related]
17. Alterations of whole-brain cortical area and thickness in mild cognitive impairment and Alzheimer's disease.
Li C; Wang J; Gui L; Zheng J; Liu C; Du H
J Alzheimers Dis; 2011; 27(2):281-90. PubMed ID: 21799248
[TBL] [Abstract][Full Text] [Related]
18. Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease.
Alcolea D; Vilaplana E; Pegueroles J; Montal V; Sánchez-Juan P; González-Suárez A; Pozueta A; Rodríguez-Rodríguez E; Bartrés-Faz D; Vidal-Piñeiro D; González-Ortiz S; Medrano S; Carmona-Iragui M; Sánchez-Saudinós M; Sala I; Anton-Aguirre S; Sampedro F; Morenas-Rodríguez E; Clarimón J; Blesa R; Lleó A; Fortea J
Neurobiol Aging; 2015 Jun; 36(6):2018-23. PubMed ID: 25865441
[TBL] [Abstract][Full Text] [Related]
19. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
Drake JD; Chambers AB; Ott BR; Daiello LA;
J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
[TBL] [Abstract][Full Text] [Related]
20. Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment.
Westman E; Aguilar C; Muehlboeck JS; Simmons A
Brain Topogr; 2013 Jan; 26(1):9-23. PubMed ID: 22890700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
